Correlation Between Unicycive Therapeutics and Regenxbio
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Regenxbio, you can compare the effects of market volatilities on Unicycive Therapeutics and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Regenxbio.
Diversification Opportunities for Unicycive Therapeutics and Regenxbio
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unicycive and Regenxbio is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Regenxbio go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Regenxbio
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 2.47 times more return on investment than Regenxbio. However, Unicycive Therapeutics is 2.47 times more volatile than Regenxbio. It trades about 0.04 of its potential returns per unit of risk. Regenxbio is currently generating about -0.03 per unit of risk. If you would invest 71.00 in Unicycive Therapeutics on September 6, 2024 and sell it today you would earn a total of 0.00 from holding Unicycive Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Regenxbio
Performance |
Timeline |
Unicycive Therapeutics |
Regenxbio |
Unicycive Therapeutics and Regenxbio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Regenxbio
The main advantage of trading using opposite Unicycive Therapeutics and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |